CDY 1.43% 7.1¢ cellmid limited

2018 - The Year of the BioTechs, page-676

  1. 1,334 Posts.
    lightbulb Created with Sketch. 1004
    The chart below correlates cash receipts with sales revenue reported for the Advangen business on a quarterly basis. There is a clear fit between the two sets of figures, with either indicating annualised trend growth for sales in the range 65%-70% pa.

    Cash vs Revenue_Q318.JPG
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.